CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that edasalonexent (CAT-1004) will be featured in an oral presentation and a poster presentation at the upcoming 2016 Parent Project Muscular Dystrophy (PPMD) Annual Connect Conference being held on Sunday, June 26 – Wednesday, June 29, 2016 at the Renaissance Orlando at Sea World Hotel in Orlando, FL.
